Literature DB >> 15935356

Is a single definition of the metabolic syndrome appropriate?--A comparative study of the USA and Asia.

A Patel1, K-C Huang, E D Janus, T Gill, B Neal, P Suriyawongpaisal, E Wong, M Woodward, R P Stolk.   

Abstract

The metabolic syndrome has been identified as an increasingly important precursor to cardiovascular diseases in many Asian populations. Our objective was to compare the contribution of component risk factors to the diagnosis of the metabolic syndrome, as defined by the Third report of the National Cholesterol Education Program Expert Panel Adult Treatment Panel (NCEP-ATPIII), in the US and selected Asian populations. Nationally representative survey data from Hong Kong, Taiwan, Thailand and the US were used. Analyses were restricted to men and women aged > or = 35 years. The age-standardized prevalence of the NCEP-ATPIII defined metabolic syndrome was highest in the US (31% in men, 35% in women), and lowest in Taiwan (11% in men, 12% in women). The component risk factors that defined the presence of the metabolic syndrome varied between countries. As expected, abnormal waist circumference was considerably more prevalent among individuals with the metabolic syndrome in the US (72% in men, 94% in women) compared with their Asian counterparts, but substantial variation was also observed between the Asian populations (13-22% in men, 38-63% in women). Furthermore, the relative contribution of other risk factors to the metabolic syndrome was also substantially different between countries. The NCEP-ATPIII definition identifies a heterogeneous group of individuals with the metabolic syndrome in different populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935356     DOI: 10.1016/j.atherosclerosis.2005.04.012

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  15 in total

1.  The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The Atherosclerosis Risk in Communities Study.

Authors:  Abhishek Vishnu; Matthew J Gurka; Mark D DeBoer
Journal:  Atherosclerosis       Date:  2015-09-21       Impact factor: 5.162

2.  The metabolic syndrome in China.

Authors:  Bernard M Y Cheung
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

3.  Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registry.

Authors:  S Goto; Y Ikeda; J C N Chan; P W F Wilson; T Cheng Yeo; C S Liau; M T Abola; G Salette; P G Steg; D L Bhatt
Journal:  Heart Asia       Date:  2011-01-01

4.  Etiology of liver cirrhosis in Japan: a nationwide survey.

Authors:  Kojiro Michitaka; Shuhei Nishiguchi; Yutaka Aoyagi; Yoichi Hiasa; Yoshio Tokumoto; Morikazu Onji
Journal:  J Gastroenterol       Date:  2009-09-30       Impact factor: 7.527

5.  Distinct component profiles and high risk among African Americans with metabolic syndrome: the Jackson Heart Study.

Authors:  Herman Taylor; Jiankang Liu; Gregory Wilson; Sherita H Golden; Errol Crook; Claude D Brunson; Micheal Steffes; William D Johnson; Jung Hye Sung
Journal:  Diabetes Care       Date:  2008-03-10       Impact factor: 19.112

6.  Prevalence of the metabolic syndrome in the United States National Health and Nutrition Examination Survey 1999-2002 according to different defining criteria.

Authors:  Bernard M Y Cheung; Kwok Leung Ong; Yu Bun Man; Louisa Y F Wong; Chu-Pak Lau; Karen S L Lam
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-08       Impact factor: 3.738

7.  The association of levels of physical activity with metabolic syndrome in rural Australian adults.

Authors:  Clare Vaughan; Adrian Schoo; Edward D Janus; Benjamin Philpot; Nathalie Davis-Lameloise; Sing Kai Lo; Tiina Laatikainen; Erkki Vartiainen; James A Dunbar
Journal:  BMC Public Health       Date:  2009-07-31       Impact factor: 3.295

8.  Association of arterial stiffness with single nucleotide polymorphism rs1333049 and metabolic risk factors.

Authors:  Suphawadee Phababpha; Upa Kukongviriyapan; Poungrat Pakdeechote; Laddawan Senggunprai; Veerapol Kukongviriyapan; Chatri Settasatian; Pyatat Tatsanavivat; Phongsak Intharaphet; Vichai Senthong; Nantarat Komanasin; Nongnuch Settasatian; Stephen E Greenwald
Journal:  Cardiovasc Diabetol       Date:  2013-06-21       Impact factor: 9.951

9.  Discordant risk: overweight and cardiometabolic risk in Chinese adults.

Authors:  Penny Gordon-Larsen; Linda S Adair; James B Meigs; Elizabeth Mayer-Davis; Amy Herring; Sheng-kai Yan; Bing Zhang; Shufa Du; Barry M Popkin
Journal:  Obesity (Silver Spring)       Date:  2013-01       Impact factor: 5.002

10.  Routine Screening and Consultation Facilitate Improvement of Metabolic Syndrome.

Authors:  Nan-He Yoon; Seunghyun Yoo; Hyekyeong Kim; Yoonjung Han
Journal:  J Korean Med Sci       Date:  2015-07-15       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.